Congratulations to our portfolio client, Synthace after being announced as a partner to Microsoft for their new biotechnology research system, together with Oxford BioMedica and researchers at Princeton University.

Microsoft hopes that the launch of its biotechnology research platform Station B, will enable faster analysis of large datasets and contribute to development of new therapeutics.

Read more from the Synthace team on augmented intelligence for pharmaceutical research and Cell and Gene therapy.